全文获取类型
收费全文 | 3746篇 |
免费 | 214篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 111篇 |
妇产科学 | 83篇 |
基础医学 | 578篇 |
口腔科学 | 62篇 |
临床医学 | 354篇 |
内科学 | 809篇 |
皮肤病学 | 132篇 |
神经病学 | 323篇 |
特种医学 | 74篇 |
外科学 | 341篇 |
综合类 | 21篇 |
一般理论 | 2篇 |
预防医学 | 405篇 |
眼科学 | 101篇 |
药学 | 290篇 |
中国医学 | 12篇 |
肿瘤学 | 264篇 |
出版年
2023年 | 39篇 |
2022年 | 58篇 |
2021年 | 112篇 |
2020年 | 73篇 |
2019年 | 80篇 |
2018年 | 95篇 |
2017年 | 68篇 |
2016年 | 88篇 |
2015年 | 95篇 |
2014年 | 146篇 |
2013年 | 183篇 |
2012年 | 294篇 |
2011年 | 334篇 |
2010年 | 187篇 |
2009年 | 146篇 |
2008年 | 266篇 |
2007年 | 248篇 |
2006年 | 244篇 |
2005年 | 233篇 |
2004年 | 215篇 |
2003年 | 183篇 |
2002年 | 182篇 |
2001年 | 37篇 |
2000年 | 30篇 |
1999年 | 41篇 |
1998年 | 28篇 |
1997年 | 30篇 |
1996年 | 22篇 |
1995年 | 25篇 |
1994年 | 12篇 |
1993年 | 17篇 |
1992年 | 14篇 |
1991年 | 6篇 |
1990年 | 14篇 |
1989年 | 10篇 |
1988年 | 13篇 |
1987年 | 8篇 |
1986年 | 6篇 |
1985年 | 8篇 |
1984年 | 12篇 |
1983年 | 7篇 |
1982年 | 7篇 |
1981年 | 7篇 |
1980年 | 7篇 |
1979年 | 7篇 |
1978年 | 5篇 |
1975年 | 5篇 |
1973年 | 6篇 |
1968年 | 6篇 |
1966年 | 4篇 |
排序方式: 共有3984条查询结果,搜索用时 15 毫秒
61.
Victoria Alegría‐Landa Margarita Jo‐Velasco Lucía Prieto‐Torres Luis Requena 《Journal of cutaneous pathology》2017,44(5):504-508
Folliculo‐sebaceous hamartomas comprise a series of entities whose boundaries are imprecise. We present the clinical case of a folliculo‐sebaceous cystic hamartoma of genital localization where the diagnosis was established based on the epithelial proliferation, but mostly, on the characteristic stroma. Because this lesion lacked of the cystic component, we mention the most frequent differential diagnoses and review the literature of the few cases published on this infrequent localization. 相似文献
62.
Rubén Martínez-Barricarte Meike Heurich Francisco Valdes-Ca?edo Eduardo Vazquez-Martul Eva Torreira Tamara Montes Agustín Tortajada Sheila Pinto Margarita Lopez-Trascasa B. Paul Morgan Oscar Llorca Claire L. Harris Santiago Rodríguez de Córdoba 《The Journal of clinical investigation》2010,120(10):3702-3712
Dense deposit disease (DDD) is a severe renal disease characterized by accumulation of electron-dense material in the mesangium and glomerular basement membrane. Previously, DDD has been associated with deficiency of factor H (fH), a plasma regulator of the alternative pathway (AP) of complement activation, and studies in animal models have linked pathogenesis to the massive complement factor 3 (C3) activation caused by this deficiency. Here, we identified a unique DDD pedigree that associates disease with a mutation in the C3 gene. Mutant C3923ΔDG, which lacks 2 amino acids, could not be cleaved to C3b by the AP C3-convertase and was therefore the predominant circulating C3 protein in the patients. However, upon activation to C3b by proteases, or to C3(H2O) by spontaneous thioester hydrolysis, C3923ΔDG generated an active AP C3-convertase that was regulated normally by decay accelerating factor (DAF) but was resistant to decay by fH. Moreover, activated C3b923ΔDG and C3(H2O)923ΔDG were resistant to proteolysis by factor I (fI) in the presence of fH, but were efficiently inactivated in the presence of membrane cofactor protein (MCP). These characteristics cause a fluid phase–restricted AP dysregulation in the patients that continuously activated and consumed C3 produced by the normal C3 allele. These findings expose structural requirements in C3 that are critical for recognition of the substrate C3 by the AP C3-convertase and for the regulatory activities of fH, DAF, and MCP, all of which have implications for therapeutic developments. 相似文献
63.
64.
Margarita Papatheodoridi Jean Baptiste Hiriart Monica Lupsor-Platon Fabrizio Bronte Jerome Boursier Omar Elshaarawy Fabio Marra Maja Thiele Georgios Markakis Audrey Payance Edgar Brodkin Laurent Castera George Papatheodoridis Aleksander Krag Umberto Arena Sebastian Mueller Paul Cales Vincenza Calvaruso Emmanuel A. Tsochatzis 《Journal of hepatology》2021,74(5):1109-1116
65.
66.
Betzana Zambrano Fernando Noriega Gustavo H. Dayan Doris Maribel Rivera Jos Luis Arredondo Humberto Reynales Kleber Luz Carmen Deseda Matthew I. Bonaparte Edith Langevin Yukun Wu Margarita Corts Stephen Savarino Carlos A. DiazGranados 《The American journal of tropical medicine and hygiene》2021,104(1):136
67.
Naniche D Lahuerta M Bardaji A Sigauque B Romagosa C Berenguera A Mandomando I David C Sanz S Aponte J Ordi J Alonso P Menendez C 《HIV medicine》2008,9(9):757-764
Objectives
Malaria infection may impact on mother‐to‐child transmission (MTCT) of HIV‐1. Prevention of malaria in pregnancy could thus potentially affect MTCT of HIV. We studied the impact of intermittent preventive treatment during pregnancy (IPTp) on HIV‐1 MTCT in southern Mozambique.Methods
A total of 207 HIV‐positive Mozambican pregnant women were enrolled in the study as part of a randomized placebo‐controlled trial of two‐dose sulfadoxine‐pyrimethamine (SP) IPTp in women receiving single‐dose nevirapine to prevent MTCT of HIV. HIV RNA viral load, maternal anaemia and peripheral and placental malaria were assessed at delivery. Infant HIV status was determined by DNA polymerase chain reaction (PCR) at 1 month of age.Results
There were 19 transmissions of HIV in 153 mother–infant pairs. IPTp with SP did not have a significant impact on MTCT (11.8% in the SP group vs. 13.2% in the placebo group; P=0.784) or on maternal HIV RNA viral load [16 312 (interquartile range {IQR} 4076–69 296) HIV‐1 RNA copies/mL in the SP group vs. 18 274 (IQR 5471–74 104) copies/mL in the placebo group; P=0.715]. In multivariate analysis, maternal HIV RNA viral load [adjusted odds ratio (AOR) 19.9; 95% confidence interval (CI) 2.3–172; P=0.006] and anaemia (haematocrit <33%; AOR 7.5; 95% CI 1.7–32.4; P=0.007) were independent risk factors for MTCT. Placental malaria was associated with a decrease in MTCT (AOR 0.23; 95% CI 0.06–0.89; P=0.034).Conclusions
IPTp with SP was not associated with a significant impact on MTCT of HIV. Maternal anaemia was an independent risk factor for MTCT. 相似文献68.
Stacee M. Lerret Marianne E. Weiss Gail L. Stendahl Shelley Chapman Jerome Menendez Laurel Williams Michelle L. Nadler Katie Neighbors Katie Amsden Yumei Cao Melodee Nugent Estella M. Alonso Pippa Simpson 《Pediatric transplantation》2015,19(1):118-129
Pediatric SOT recipients are medically fragile and present with complex care issues requiring high‐level management at home. Parents of hospitalized children have reported inadequate preparation for discharge, resulting in problems transitioning from hospital to home and independently self‐managing their child's complex care needs. The aim of this study was to investigate factors associated with the transition from hospital to home and chronic illness care for parents of heart, kidney, liver, lung, or multivisceral recipients. Fifty‐one parents from five pediatric transplant centers completed questionnaires on the day of hospital discharge and telephone interviews at three wk, three months, and six months following discharge from the hospital. Care coordination (p = 0.02) and quality of discharge teaching (p < 0.01) was significantly associated with parent readiness for discharge. Readiness for hospital discharge was subsequently significantly associated with post‐discharge coping difficulty (p = 0.02) at three wk, adherence with medication administration (p = 0.03) at three months, and post‐discharge coping difficulty (p = 0.04) and family management (p = 0.02) at six months post‐discharge. The results underscore the important aspect of education and care coordination in preparing patients and families to successfully self‐manage after hospital discharge. Assessing parental readiness for hospital discharge is another critical component for identifying risk of difficulties in managing post‐discharge care. 相似文献
69.
Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation 总被引:11,自引:0,他引:11 下载免费PDF全文
Yang SH Bergo MO Toth JI Qiao X Hu Y Sandoval S Meta M Bendale P Gelb MH Young SG Fong LG 《Proceedings of the National Academy of Sciences of the United States of America》2005,102(29):10291-10296
Hutchinson-Gilford progeria syndrome (HGPS), a progeroid syndrome in children, is caused by mutations in LMNA (the gene for prelamin A and lamin C) that result in the deletion of 50 aa within prelamin A. In normal cells, prelamin A is a "CAAX protein" that is farnesylated and then processed further to generate mature lamin A, which is a structural protein of the nuclear lamina. The mutant prelamin A in HGPS, which is commonly called progerin, retains the CAAX motif that triggers farnesylation, but the 50-aa deletion prevents the subsequent processing to mature lamin A. The presence of progerin adversely affects the integrity of the nuclear lamina, resulting in misshapen nuclei and nuclear blebs. We hypothesized that interfering with protein farnesylation would block the targeting of progerin to the nuclear envelope, and we further hypothesized that the mislocalization of progerin away from the nuclear envelope would improve the nuclear blebbing phenotype. To approach this hypothesis, we created a gene-targeted mouse model of HGPS, generated genetically identical primary mouse embryonic fibroblasts, and we then examined the effect of a farnesyltransferase inhibitor on nuclear blebbing. The farnesyltransferase inhibitor mislocalized progerin away from the nuclear envelope to the nucleoplasm, as determined by immunofluoresence microscopy, and resulted in a striking improvement in nuclear blebbing (P < 0.0001 by chi2 statistic). These studies suggest a possible treatment strategy for HGPS. 相似文献
70.
Schellenberg D Menendez C Aponte J Guinovart C Mshinda H Tanner M Alonso P 《Tropical medicine & international health : TM & IH》2004,9(1):68-76
Between 1995 and 2000 there were marked changes in the epidemiology of malaria in Ifakara, southern Tanzania. We documented these changes using parasitological and clinical data from a series of community- and hospital-based studies involving children up to the age of 5 years. There was a right shift and lowering in the age-specific parasite prevalence in the community-based cohort studies. The incidence of clinical malaria in placebo-receiving infants in additional study cohorts dropped from 0.8 in 1995 to 0.43 episodes per infant per year in 2000, an incidence rate ratio of 0.53 (95% confidence interval: 0.404, 0.70, P<0.0001). At the same time, there was an increase in the total number of malaria admissions and a marked right shift in the age pattern of these admissions (median age in 1995 1.55 years vs. 2.33 in 2000, P<0.0001). However, the burden of malaria deaths remained in infants. We discuss how these dramatic changes in the epidemiology of malaria may have arisen from the use of currently available malaria control tools. Caution is required in the interpretation of hospital-based data as it is likely to underestimate the impact of anaemia on mortality in the community, where most paediatric deaths occur. Even in low/moderate malaria transmission settings, where older children suffer most malaria episodes, targeting effective malaria control at infants may produce important reductions in infant mortality caused by malaria. 相似文献